Caplight Directory>Investors>Newpath Partners>Newpath-partners


Newpath Partners

Newpath Partners

Boston, Massachusettsnewpath.partners

Overview

Newpath Partners is a venture capital firm dedicated to excellent science and to forming partnerships based on trust and a shared vision . The firm focuses on venture capital investments in disruptive treatments and technologies in the life sciences space . Newpath collaborates with academics and founders to translate scientific discoveries into biotechnology companies across the US .

Year Founded

2018

Portfolio Companies

14

Investments

CompanyDateStageLead
CREATE MedicinesMay 2026Series BLead
Leal TherapeuticsAug 2025Series ACo-investor
nChroma BioDec 2024Series ILead
MetseraNov 2024Series B-
Leal TherapeuticsOct 2024VC RoundLead
View all investments

Key People

Daniel Yadegar

Co-Founder and Chief Medical Officer

Thomas Cahill

Co-Founder

Tom M. Thomas

Investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.